Cargando…
Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians
PURPOSE: Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemotherapy in ER-positive, HER2-negative, early-stage breast cancer. As health literacy and numeracy skills in the general population are poor, healthcare professionals (HCPs) require...
Autores principales: | Fallowfield, L., Solis-Trapala, I., Starkings, R., Catt, S., May, S., Jenkins, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745030/ https://www.ncbi.nlm.nih.gov/pubmed/31201584 http://dx.doi.org/10.1007/s10549-019-05316-7 |
Ejemplares similares
-
Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing
por: Fallowfield, Lesley, et al.
Publicado: (2022) -
Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing
por: Shilling, Valerie, et al.
Publicado: (2020) -
Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study
por: Jenkins, V, et al.
Publicado: (2013) -
IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer
por: Fallowfield, L. J., et al.
Publicado: (2022) -
Enduring impact of communication skills training: results of a 12-month follow-up
por: Fallowfield, L, et al.
Publicado: (2003)